News Quest Diagnostics Incorporated

Equities

DGX

US74834L1008

Market Closed - Nyse Other stock markets 04:00:02 2024-04-23 pm EDT			5-day change	1st Jan Change
136.7 ^USD	+5.08%		+7.28%	-0.86%

Apr. 23	Evercore ISI Raises Quest Diagnostics Price Target to $145 from $140	MT
Apr. 23	Sector Update: Health Care Stocks Steady Pre-Bell Tuesday	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Evercore ISI Raises Quest Diagnostics Price Target to $145 from $140	Apr. 23	MT
Quest Diagnostics Incorporated : First Quarter 2024 View Transcript of Company Prepared Comments	Apr. 23	PU
Sector Update: Health Care Stocks Steady Pre-Bell Tuesday	Apr. 23	MT
Transcript : Quest Diagnostics Incorporated, Q1 2024 Earnings Call, Apr 23, 2024	Apr. 23
Quest Diagnostics Posts Flat Q1 Adjusted Earnings, Revenue Rises; 2024 Earnings, Revenue Guidance Raised	Apr. 23	MT
Earnings Flash (DGX) QUEST DIAGNOSTICS Reports Q1 Revenue $2.37B, vs. Street Est of $2.29B	Apr. 23	MT
Earnings Flash (DGX) QUEST DIAGNOSTICS Posts Q1 EPS $2.04, vs. Street Est of $1.86	Apr. 23	MT
Quest Diagnostics: Q1 Earnings Snapshot	Apr. 23	AQ
Quest Diagnostics Incorporated Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 23	CI
Quest Diagnostics Reports First Quarter 2024 Financial Results; Raises Guidance for Full Year 2024	Apr. 23	PR
Quest Diagnostics Incorporated Updates Earnings Guidance for the Full Year of 2024	Apr. 23	CI
MORNING BID AMERICAS-Tanking Tesla reports, Europe business beats	Apr. 23	RE
Quest Diagnostics Launches New Test to Help Assess Alzheimer's Disease Risk	Apr. 22	MT
Quest Diagnostics Adds p-tau217 Blood Biomarker Testing to Suite of Services Designed to Assess Risk and Help Aid Diagnosis of Alzheimer's Disease	Apr. 22	PR
Quest Diagnostics Adds p-tau217 Blood Biomarker Testing to Suite of Services Designed to Assess Risk and Help Aid Diagnosis of Alzheimer's Disease	Apr. 22	CI
John Chevedden Files an Exempt Solicitation Statement with Securities and Exchange Commission	Apr. 11	CI
Quest Diagnostics Receives Shareholder Proposal from John Chevedden	Apr. 05	CI
Ex-dividend day	Apr. 04	FA
Quest Diagnostics and Broad Clinical Labs to Evaluate Whole Genome Sequencing as First-Line Genetic Test for Developmental Delay	Apr. 03	AQ
Quest Collaborating With Broad Clinical Labs to Assess Whole Genome Sequencing Test for Developmental Delay Disorders	Apr. 02	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Quest Diagnostics Incorporated

Equities

DGX

US74834L1008

Summary

Filters